We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $52.8B
1-Year Est. Return 58.98%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+58.98%
3 Year Est. Return
+167.96%
5 Year Est. Return
+202.28%
10 Year Est. Return
+627.19%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
926
Bristol-Myers Squibb
BMY
$132B
$1.05M ﹤0.01%
17,279
-169,116
-91% -$9.86M
ROAD icon
927
Construction Partners
ROAD
$6.73B
$1.05M ﹤0.01%
14,641
-4,445
-23% -$350K
TRNO icon
928
Terreno Realty
TRNO
$7.5B
$1.05M ﹤0.01%
+16,604
New +$1.08M
DAO
929
Youdao
DAO
$2.11B
$1.05M ﹤0.01%
137,456
+62,568
+84% +$516K
CVNA icon
930
Carvana
CVNA
$81B
$1.05M ﹤0.01%
+24,995
New +$1.11M
PCB icon
931
PCB Bancorp
PCB
$400M
$1.04M ﹤0.01%
55,647
+7,486
+16% +$145K
AAMI
932
Acadian Asset Management
AAMI
$3.31B
$1.04M ﹤0.01%
40,258
+30,886
+330% +$777K
HOOD icon
933
Robinhood
HOOD
$89.3B
$1.04M ﹤0.01%
+24,931
New +$1.19M
MGNX icon
934
MacroGenics
MGNX
$259M
$1.04M ﹤0.01%
816,054
+71,152
+10% +$186K
PBR.A icon
935
Petrobras Class A
PBR.A
$104B
$1.04M ﹤0.01%
79,475
-178,978
-69% -$2.25M
MRK icon
936
Merck
MRK
$334B
$1.03M ﹤0.01%
11,523
-291,231
-96% -$27.2M
MDXG icon
937
MiMedx Group
MDXG
$612M
$1.03M ﹤0.01%
135,894
+27,899
+26% +$233K
HBNC icon
938
Horizon Bancorp
HBNC
$1.05B
$1.03M ﹤0.01%
68,290
+30,933
+83% +$502K
IHG icon
939
InterContinental Hotels
IHG
$23.5B
$1.03M ﹤0.01%
9,378
-7,203
-43% -$896K
HSIC icon
940
Henry Schein
HSIC
$10B
$1.02M ﹤0.01%
+14,946
New +$1.1M
ERIC icon
941
Ericsson
ERIC
$33.6B
$1.02M ﹤0.01%
131,852
+6,300
+5% +$50.9K
KN icon
942
Knowles
KN
$3.23B
$1.02M ﹤0.01%
67,085
-107,000
-61% -$1.92M
WVE icon
943
Wave Life Sciences
WVE
$1.02B
$1.02M ﹤0.01%
126,046
-261,825
-68% -$2.86M
SXT icon
944
Sensient Technologies
SXT
$5.53B
$1.02M ﹤0.01%
13,659
-15,189
-53% -$1.11M
STZ icon
945
Constellation Brands
STZ
$23.3B
$1.02M ﹤0.01%
5,531
-16,340
-75% -$2.97M
RITM icon
946
Rithm Capital
RITM
$5.79B
$1.01M ﹤0.01%
+88,362
New +$1.02M
NIC icon
947
Nicolet Bankshares
NIC
$3.73B
$1.01M ﹤0.01%
9,256
+1,838
+25% +$207K
GDOT icon
948
Green Dot
GDOT
$770M
$1.01M ﹤0.01%
119,078
-24,294
-17% -$206K
WNEB icon
949
Western New England Bancorp
WNEB
$282M
$1M ﹤0.01%
107,813
+12,189
+13% +$112K
VTYX
950
DELISTED
Ventyx Biosciences
VTYX
$1M ﹤0.01%
871,605
+78
+0% +$134

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.